@GrailBio #gral They simply said that the test works ( it was always known). What mattered more is they wondering what to do with the positive or negative test information. You want insurance to pay for it and insurance is not going to pay for it without evidence that it helps!.
Today GRAIL announced a favorable vote from an FDA Advisory Committee for the approval of the Premarket Approval application of the Galleri multi-cancer early detection test (MCED).
The Committee considered Galleri’s safety, effectiveness, and overall benefit-risk profile for screening for the early detection of multiple types of cancer in adults aged 50 years and older.
Read more: bit.ly/4rpmwUd
#MCED #Galleri #CancerScreening
1
70
2/ You may ask why? If the test is positive, the insurance has to bear all the burden of confirming what the positive test means. A doctor has no choice but to follow up with more tests and insurance has to pay for it only to learn that everything is ok.
Sep 24, 2026 · 1:33 PM UTC
1
13